Ask a Question

User thinguse69

Member for: 2 days (since Sep 25)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/ipi-549.html
About: Neoadjuvant Trastuzumab, Pertuzumab, as well as Docetaxel as opposed to Trastuzumab Emtansine in Individuals Along with ERBB2-Positive Breast Cancer: The Cycle Only two Randomized Medical trial.

Activity by thinguse69

Score: 100 points (ranked #321)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for thinguse69

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...